In the complex landscape of healthcare, patients often find themselves facing unexpected medical bills, leading to financial strain and confusion. To address this issue, Good Faith Estimates (GFEs) have emerged as a valuable tool. They aim to provide patients with greater financial transparency and empower them to make informed decisions about their healthcare.
Consequently, GFEs are a product of the No Surprises Act, which went into effect in 2022. With transparency undoubtedly becoming a prominent component of the healthcare industry, Good Faith Estimates are already becoming a vital part of any practice or lab involved with diagnostic testing and medical costs. Frequently asked questions about Good Faith Estimates include:
Good Faith Estimates: What’s to Know?
Adjusting to this new standard of healthcare can be daunting. If GFEs are creating a burden, we can help. careviso’s product seeQer, specializes in answering the cost and coverage questions plaguing patients, providers, and payors. Furthermore, by identifying out-of-pocket costs in advance, seeQer alleviates the burden associated with GFEs and empowers individuals to make informed decisions about their healthcare.
careviso is a healthcare technology company supporting everyone involved in diagnostic testing. We created a proprietary platform for payors, physicians, and laboratories that improves patient care through streamlined workflows. By automating the impossible we’re solving the most complex problems in the healthcare industry: prior authorizations and financial transparency.